Funding Rounds
Ariceum Therapeutics

Ariceum Therapeutics Series A (2023, $24M)

Ariceum Therapeutics

Diagnosis and treatment of hard-to-treat cancers.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $24.95M

Investors